Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes

Details for Australian Patent Application No. 2003228508 (hide)

Owner Celgene Corporation

Inventors Zeldis, Jerome B

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003228508

PCT Number PCT/US03/11323

PCT Pub. Number WO2004/035064

Priority 60/418,468 15.10.02 US

Filing date 13 April 2003

Wipo publication date 4 May 2004

Acceptance publication date 23 October 2008

International Classifications

A61K 31/454 (2006.01)

A61K 31/07 (2006.01)

A61K 31/285 (2006.01)

A61K 31/4745 (2006.01)

A61K 31/573 (2006.01)

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 60/418,468 15.10.02 US

10 June 2004 Application Open to Public Inspection

  Published as AU-B-2003228508

23 October 2008 Application Accepted

  Published as AU-B-2003228508

19 February 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003228509-Selective cytokine inhibitory drugs for treating myelodysplastic syndrome

2003228507-SEALING COMPRESSION FERRULE FOR PLUMBING CONNECTION FITTING